Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by inventorson Nov 17, 2015 12:40pm
257 Views
Post# 24297961

Re: Bounce

Re: Bounce
PLI elongated bounce...with a good month past seasonal adjustments...lol. The seasonal rotation equity clocked changed along the way to extend heathcare index trend to Dec 4...cough...a new one should be starting and finsh by fiscal spring year out...lol.
 
And why not, since china dumped its fiat load, analyst were unloading banks, materials, and healthcare. They said dip back into gold...lol.
 
Technically, both McWhirter $3.00 mark and the other sub $2.00 marks were correct...stuck right in the middle...or golden cross in the mix.
 
Incidentially, Thomvest has $3.00 consideration in the mix, along with other major warrants, and potential for margin...

Investors are taking new partner business with orphan FDA's more serious...anyone have a $3.50 marching order...lol.

Bullboard Posts